Found 88 matching trials
Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia PHASE2 This phase II trial studies how well a dose adjusted regimen consisting of ...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects PHASE2 This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Erbium-doped Yttrium Aluminium Garnet Laser(Er:Yag)Associated With Amorolfine Lacquer in the Treatment of Onychomycosis PHASE2 The study aims to investigate the effectiveness of a single application of ...
Show More Location
University Hospital of Brasilia
Learn More & Join Trial
Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma PHASE3 B-cell non-Hodgkin's lymphoma (B-NHL) is the most common type of NHL. Altho...
Show More Location
Shandong Provincial Hospital
Learn More & Join Trial
Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation PHASE2 Phase II trial to determine the efficacy of Dose Adjusted-EPOCH-Rituximab r...
Show More Location
University Hospitals Leuven
Learn More & Join Trial
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas PHASE2 This phase II/III trial tests whether it is possible to decrease the chance...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma PHASE1 The purpose of this study is to evaluate the effects, good and bad of a new...
Show More Location
Northwestern University
Learn More & Join Trial
Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia PHASE2 This phase II clinical trial tests a chemotherapy regimen (dose-adjusted et...
Show More Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
CNS Prophylaxis in Diffuse Large B-cell Lymphoma PHASE3 Comparison of cumulative incidence of CNS relapses in patients with diffuse...
Show More Location
University Hospital Brno-Bohunice
Learn More & Join Trial
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma PHASE3 This study utilizes a prospective, multicenter, randomized two-arm design t...
Show More Location
Dongyang People's Hospital
Learn More & Join Trial